Compositions comprising PCSK9-binding molecules and methods of use
Abstract:
The present disclosure provides pharmaceutical compositions comprising fibronectin based scaffold domain proteins that bind, for example, proprotein convertase subtilisin kexin-9 (PCSK9).
Public/Granted literature
Information query
Patent Agency Ranking
0/0